EIM
SRGA

Essex Investment Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Essex Investment Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,619
Closed -$2M – 478
2021
Q1 		$2M Buy
+30,619
New +$2.14M 0.24% 142

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Essex Investment Management's SRGA Position: Q2 2021 in Review

Essex Investment Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 30,619 shares — an estimated $2M sold.

Essex Investment Management first reported a position in SRGA in Q1 2021 and held it in 1 quarter. The position peaked at $2M in Q1 2021. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.

  • Essex Investment Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Essex Investment Management sold 30,619 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $2M.
  • Essex Investment Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Essex Investment Management's Surgalign Holdings, Inc. Common Stock position peaked at $2M in Q1 2021.
  • 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.

Based on Essex Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.